Seth Klarman’s Boston-based firm counted three small drug companies among its ten largest positions last quarter and recently revealed new positions in the sector.
Stephen TaubDecember 15, 2014
Seth Klarman, Baupost Group (Bloomberg)Famed value investor Seth Klarman’s Baupost Group is exploring a new investing theme, building a portfolio of fledgling pharmaceutical companies. In the past month or two, the Boston-based investment firm
To continue reading, subscribe now to Premium Journalism. Already a subscriber? login.